Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine for Pegfilgrastim-Induced Pain
NCT01311336Phase 2Unknown
- Sponsor
- The University of Vermont
- Start
- May 2011
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of loratadine in bone pain, sponsored by The University of Vermont. Status: unknown.
02
Drugs
loratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT01311336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01311336.